ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/02222710CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120161012W173deBibliographieenBibliographyfrBibliographieEP08864495.0200812232010062220140819enenen16524 P20071224US56206 P20080527US2016101220164120100901201035201607272016302016062220161012201641C07K 19/00 20060101AFI20121218BHEP A61K 39/00 20060101ALI20121218BHEP A61K 39/155 20060101ALI20121218BHEP A61K 39/295 20060101ALI20121218BHEP A61K 9/107 20060101ALI20121218BHEP A61K 9/127 20060101ALI20121218BHEP A61P 31/14 20060101ALI20121218BHEP A61P 37/04 20060101ALI20121218BHEP C07K 14/135 20060101ALI20121218BHEP C12N 15/45 20060101ALI20121218BHEP C12N 15/62 20060101ALI20121218BHEP C07K 14/005 20060101ALI20121218BHEP deREKOMBINANTE RSV-ANTIGENEenRECOMBINANT RSV ANTIGENSfrANTIGÈNES RECOMBINANTS DU RSVWO-A2-2008/114149WO-A2-2008/154456YIN HSIEN-SHENG ET AL: "Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 439, no. 7072, 1 January 2006 (2006-01-01), pages 38-44, XP002503490, ISSN: 0028-0836, DOI: 10.1038/NATURE04322BEGONA RUIZ-ARGUELLO M ET AL: "Effect of Proteolytic Processing at Two Distinct Sites on Shape and Aggregation of an Anchorless Fusion Protein of Human Respiratory Syncytial Virus and Fate of the Intervening Segment", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 298, no. 2, 5 July 2002 (2002-07-05), pages 317-326, XP004469494, ISSN: 0042-6822, DOI: 10.1006/VIRO.2002.1497VAN DRUNEN LITTEL-VAN DEN HURK S ET AL: "Immunopathology of RSV infection: prospects for developing vaccines without this complication", REVIEWS IN MEDICAL VIROLOGY, CHICHESTER, GB, vol. 17, no. 1, 1 January 2007 (2007-01-01), pages 5-34, XP002510797, ISSN: 1052-9276, DOI: 10.1002/RMV.518 [retrieved on 2006-09-27]PRINCE GREGORY A ET AL: "Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 22, 1 November 2000 (2000-11-01), pages 10287-10292, XP002676837, ISSN: 0022-538XSINGH ET AL: "Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model", VACCINE, ELSEVIER LTD, GB, vol. 25, no. 33, 24 July 2007 (2007-07-24) , pages 6211-6223, XP022168621, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.05.068TERNETTE ET AL: "Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus", VACCINE, ELSEVIER LTD, GB, vol. 25, no. 41, 27 September 2007 (2007-09-27), pages 7271-7279, XP022276681, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.07.025CALDER L J ET AL: "Electron Microscopy of the Human Respiratory Syncytial Virus Fusion Protein and Complexes That It Forms with Monoclonal Antibodies", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 271, no. 1, 25 May 2000 (2000-05-25), pages 122-131, XP004436029, ISSN: 0042-6822, DOI: 10.1006/VIRO.2000.0279ULBRANDT NANCY D ET AL: "Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 89, no. Part 12, 1 December 2008 (2008-12-01), pages 3113-3118, XP002604581, ISSN: 0022-1317, DOI: 10.1099/VIR.0.2008/005199-0MARTIN, D. ET AL.: 'Sequence elements of the fusion peptide of human respiratory syncytial viru fusion protein required for activity.' JOURNAL OF GENERAL VIROLOGY vol. 87, no. 6, June 2006, pages 1649 - 1658, XP002600413GONZALEZ-REYES, L. ET AL.: 'Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.' PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA vol. 98, no. 17, 14 August 2001, pages 9859 - 9864, XP008136810YIN, H.-S. ET AL.: 'Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation.' NATURE vol. 439, no. 7072, 05 January 2006, pages 38 - 44, XP002600415SCHMIDT, A. C. ET AL.: 'Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.' JOURNAL OF VIROLOGY vol. 76, no. 3, February 2002, pages 1089 - 1099, XP002978183HUANG Y. ET AL.: 'Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.' JOURNAL OF VIROLOGY vol. 79, no. 7, April 2005, pages 4527 - 4532, XP002600416TANG, R. S. ET AL.: 'Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys.' JOURNAL OF VIROLOGY vol. 78, no. 20, October 2004, pages 11198 - 11207, XP002600417VALARCHER, J.-F. ET AL.: 'Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves.' JOURNAL OF GENERAL VIROLOGY vol. 87, no. 6, June 2006, pages 1659 - 1667, XP0081367642013010216180926.420160725BAUDOUX, Jean-PierreRue de l'Institut 89B-1330 RixensartBEBLAIS, Normand525 Cartier QuestLaval Québec H6V 3S8CARHEAULT, Patrick525 Cartier OuestLaval Québec H7V 3S8CARUELLE, Jean-LouisRue de l'Institut 89B-1330 RixensartBEID Biomedical Corporation of Quebec101605270KMC/VU627882323 Boul. du Parc Technologique Ste FoyQuebec G1P 4R8CAGlaxoSmithKline Biologicals S.A.100825659KMC/VU62788Rue de l'Institut, 891330 RixensartBEThornley, Rachel Maryet al101323158GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMTNLNOPLPTROSESISKTRAL20100622BA20100622MK20100622RS20100622CA200800227720081223enWO20090797962009070220092720100901201035